COVID-19 疫情期间临床试验管理:临床研究机构的实践经验
本文基于一家管理学术与商业临床试验的临床研究机构的一手经验,梳理疫情大流行期间临床试验管理中出现的关键问题,并给出解决方案的实践指导。文章强调试验经理需及时解决问题以维持试验开放,并确保参与者安全这一首要事项得到监测。
要点
- 疫情封锁下临床试验面临不确定性,参与者保留与脱落是潜在威胁试验完成的关键问题。
- 试验经理需及时问题求解以维持试验开放,并将参与者安全监测置于首位。
- 文章从一手经验出发提供解决方案的实践指导。
核心结论
- 疫情大流行期间临床试验管理需试验经理及时问题求解,以维持试验开放并确保参与者安全得到监测。
研究设计与样本
- 基于一家管理学术与商业临床试验的临床研究机构的一手经验总结。
主要发现
- 疫情封锁使全球临床试验的持续开展陷入不确定状态。
- 参与者保留是临床试验的持续问题,当前疫情环境下脱落可能危及试验完成。
- 当前形势要求试验经理及时问题求解以确保试验保持开放。
临床怎么用
- 文章提供解决方案实施的实践指导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is a dearth of literature on best practices for managing clinical trials, and little is understood on the role of the clinical trial manager. The COVID-19 pandemic has brought this into focus, and the continuance of clinical trials worldwide has been catapulted into a state of uncertainty as countries enter lockdown to manage the spread of the virus. Participant retention is an ongoing issue in clinical trials, and the concern is that in the current pandemic environment, attrition will be an issue which could potentially jeopardise trial completion. The current situation has necessitated timely problem solving by the trial manager to ensure trials remain open, and most importantly, that participant safety, paramount in clinical trials, is monitored. The purpose of our study is to highlight key issues arising in the management of clinical trials during a pandemic from first-hand experience in a clinical research facility managing both academic and commercial clinical trials. We offer some practical guidance on solution implementation.
引用
- Shiely F, Foley J, Stone A, et al. Managing clinical trials during COVID-19: experience from a clinical research facility. Trials. 2021. PMID: 33461595. doi:10.1186/s13063-020-05004-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。